Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-03-31 2022-12-20 157650
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-04-28 2023-01-19 159584
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2022-06-16 2023-04-28 162846
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 2000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2019-06-27 2019-11-07 87653
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2025-04-04 2025-04-24 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739
APRI 21 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173067
APRI 21 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10868
APRI 28 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10871
APRI 28 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173064
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660

Showing 301 to 320 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81418
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81381
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142915
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142918
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142921
TEVA-DILTIAZEM T 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115126
TEVA-DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117
TEVA-DILTIAZEM T 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115120
TEVA-DILTIAZEM T 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115123
TEVA-DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
ACT DONEPEZIL ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64872
ACT DONEPEZIL ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64875
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529

Showing 1 to 20 of 300